Esperion Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Tim Mayleben Thank you, Mindy. I’d also like to welcome all of you to Esperion’s first quarterly conference call. On today’s call I’ll provide an overall update on the ETC-1002 development program and … more

View todays social media effects on ESPR

View the latest stocks trending across Twitter. Click to view dashboard

See who Esperion is hiring next, click here to view